Global Proteomics | Next-Generation Proteomics | Large-Scale Proteomics
Contact us Helpdesk

Powering precision medicine into reality

The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making.

OUR STORY

Transformative insights from discovery to clinic

Unbiased biological insights from tissue and biofluids

Novel drug target identification and validation

Custom panels for absolute protein quantification

Biognosys is the world leader in next-generation proteomics contract research services to support pharma and biotech research and clinical development.

OUR SERVICES

We offer a complete suite of software solutions for any mass spectrometry proteomics application in industry or academic life sciences research.

OUR SOFTWARE

Our kits and reagents for sample preparation, quantification and quality control empower researchers to apply cutting-edge proteomics in-house.

OUR KITS

 

Latest News & Stories

News
Biognosys Announces Appointment of Beat Lüthi, Ph.D., as independent Board Director

The appointment will support Biognosys’ transformation to a leading provider of protein insights for the development of new breakthrough[...]

READ MORE
News
Biognosys and NeoGenomics Expand Global Strategic Partnership Initiatives on Multiple Discovery Proteomics Solutions Supporting Biopharma R&D

Biognosys’ leading discovery proteomics services to add depth to NeoGenomics’ multiomics solutions for biopharma clinical trials and[...]

READ MORE
News
Biognosys Presenting Data on its TrueDiscovery™ and TrueTarget™ Proteomics Platforms at the AACR Annual Meeting 2022

Data from Biognosys and its collaborators demonstrate the technological advances and utility of their proteomics platforms in oncology R&D and clinical[...]

READ MORE
News
Biognosys Launches Expanded Suite of Proteomics Platforms to Support Drug Research and Development

The TrueDiscovery™, TrueTarget™, and TrueSignature™ platforms provide an integrated suite of research services that reveal deep biological insights from early stage[...]

READ MORE
News
Biognosys Partners with Kymera Therapeutics in Precision Proteomics Biomarkers

Biognosys’ TrueSignature™ proteomics panels serve as pharmacodynamic readout for protein degradation in Kymera’s discovery and clinical trial[...]

READ MORE
News
Biognosys Launches Next-Generation Blood Biomarker Discovery Solution

The new and improved service will offer unprecedented depth, precision, and throughput, quantifying up to 3,000 proteins in plasma or[...]

READ MORE
News
Get Free Access to Our Software with Your Next PQ500™ Purchase

The limited-time offer includes a choice of 6 free months of SpectroDive™, our software for targeted proteomics, OR 3 free months of Spectronaut™, our DIA analysis[...]

READ MORE
News
Biognosys Reaches New Milestone in Tissue Proteomics

With a depth of up to 13,000 proteins, Biognosys’ proprietary HRM™ technology now enables near-complete quantification of tissue proteomes. [...]

READ MORE
News
Biognosys Announces GLP Certification of its Proteomics Facility by the Swiss Health Authorities

Biognosys is the first global proteomics service provider that is GLP certified for preclinical studies and GCP compliant for clinical[...]

READ MORE
News
Biognosys in Publications 2021

A growing number of scientific publications have been using Biognosys' technology and tools in[...]

READ MORE
News
Biognosys Expands Co-Marketing Agreement with Global Life Science Leader to Advance Proteomics

The agreement with Thermo Fisher Scientific is providing life science researchers with comprehensive mass spectrometry solutions to gain deep proteomic insights at a large[...]

READ MORE
News
SpectroMine 3 is here! Unearth the Full Potential of DDA Proteomics

SpectroMine 3 comes with many novel and enhanced features for unsurpassed performance for DDA[...]

READ MORE

Join Email List

    Select any of the below topic preferences: By submitting this form, you confirm that you agree to the processing of your personal data by Biognosys as described in the Privacy Notice.

    Join the Biognosys email list to receive news and exclusive content.

    Join Email List

      Select any of the below topic preferences: By submitting this form, you confirm that you agree to the processing of your personal data by Biognosys as described in the Privacy Notice.